Ghv7HF46BG
N-[[3,5-dichloro-4-(2,6-dioxopiperidin-3-yl)phenyl]methyl]-2-methyl-2-(5-methylpyrimidin-2-yl)propanamide
Molecular Identity
Ghv7HF46BG
N-[[3,5-dichloro-4-(2,6-dioxopiperidin-3-yl)phenyl]methyl]-2-methyl-2-(5-methylpyrimidin-2-yl)propanamide
PubChem CID: 176157253
2D Structure
Properties
C21H22Cl2N4O3
Molecular Formula
449.30
Molecular Weight
g/mol
448.1069
Exact Mass
Da
2.6
XLogP
Drug-like (Lipinski: < 5)
101
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
5
H-Bond Acceptors
655
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CN=C(N=C1)C(C)(C)C(=O)NCC2=CC(=C(C(=C2)Cl)C3CCC(=O)NC3=O)ClIsomeric SMILES
SMILES: CC1=CN=C(N=C1)C(C)(C)C(=O)NCC2=CC(=C(C(=C2)Cl)C3CCC(=O)NC3=O)ClSynonyms(10)
3069891-91-1GHV7HF46BGorb3181307SCHEMBL31292236BDBM761035MRT-8102EX-A15659US20250243180, Compound 142-Pyrimidineacetamide, N-[[3,5-dichloro-4-(2,6-dioxo-3-piperidinyl)phenyl]methyl]-alpha,alpha,5-trimethyl-N-[[3,5-Dichloro-4-(2,6-dioxo-3-piperidinyl)phenyl]methyl]-alpha,alpha,5-trimethyl-2-pyrimidineacetamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Ghv7HF46BG
Loading drug network...